![Mitchell Glass](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mitchell Glass
Chief Tech/Sci/R&D Officer at
Q/C TECHNOLOGIES, INC.
Net worth: 29 000 $ as of 2026-08-30
Profile
Dr. Mitchell Glass, MD, is a Director & Chief Medical Officer at Q/C Technologies, Inc., a Chairman at Accolade Pharma LLC and a Chief Executive Officer & Director at Chronic Airway Therapeutics Pty Ltd. He is on the Board of Directors at Q/C Technologies, Inc., Avatar Biotechnologies LLC, Orphagenix, Inc. and Chronic Airway Therapeutics Pty Ltd. Dr. Glass was previously employed as a Chief Medical Officer by Invion Ltd., a Chief Executive Officer by Aqumen Biopharmaceuticals NA, Inc., a Chief Scientific Officer by University City Science Center, a Chief Medical Officer & VP-Regulatory Affairs by AtheroGenics, Inc., a Director & Vice President by Smithkline Beecham Corp., a Principal by ICI Pharmaceuticals, a Chief Executive Officer by Aqumen Biopharmaceuticals KK, a Principal by Inverseon, Inc., a Chief Medical Officer & EVP-Research & Development by Invion Ltd., and a Principal by University of Pennsylvania.
He received his undergraduate degree from The University of Chicago and a doctorate degree from The University of Chicago.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-25 | 12,500 ( 0.15% ) | 29 000 $ | 2026-08-30 |
Mitchell Glass active positions
| Companies | Position | Start |
|---|---|---|
| Q/C TECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 2024-06-12 |
Accolade Pharma LLC
 Accolade Pharma LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Chairman | - |
Chronic Airway Therapeutics
 Chronic Airway Therapeutics BiotechnologyHealth Technology Develops treatments for chronic respiratory diseases | Chief Executive Officer | - |
Avatar Biotechnologies LLC | Director/Board Member | 2010-04-12 |
Orphagenix, Inc. | Director/Board Member | 2010-04-12 |
Former positions of Mitchell Glass
| Companies | Position | End |
|---|---|---|
| INVION LIMITED | Chief Tech/Sci/R&D Officer | 2019-02-28 |
| INVION LIMITED | Director/Board Member | 2019-02-11 |
Inverseon, Inc.
 Inverseon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Corporate Officer/Principal | 2012-08-31 |
Aqumen Biopharmaceuticals NA, Inc. | President | 2008-01-01 |
| ░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Mitchell Glass
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
97
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
Orphagenix, Inc. | |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University City Science Center
 University City Science Center Investment Trusts/Mutual FundsMiscellaneous Provides physical space, resources and other support to the community | Miscellaneous |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Aqumen Biopharmaceuticals KK
 Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Develops and researches therapeutic medicines | Health Technology |
Inverseon, Inc.
Inverseon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Aqumen Biopharmaceuticals NA, Inc. | |
Avatar Biotechnologies LLC | |
Invion Ltd.
 Invion Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Health Technology |
Accolade Pharma LLC
Accolade Pharma LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
MyMD Pharmaceuticals, Inc.
 MyMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that engages in the development of drug products to extend healthy lifespan | Health Technology |
Chronic Airway Therapeutics
Chronic Airway Therapeutics BiotechnologyHealth Technology Develops treatments for chronic respiratory diseases | Health Technology |
- Stock Market
- Insiders
- Mitchell Glass
